ARVN Arvinas, Inc.
Healthcare$9.09-0.11%ClosedMarket Cap: $586.5M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
1.50
P/S
6.56
EV/EBITDA
-2.19
DCF Value
$-123.93
FCF Yield
-43.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
97.4%
Operating Margin
-279.3%
Net Margin
-247.5%
ROE
-44.4%
ROA
-34.2%
ROIC
-46.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $15.6M | 92.9% | $-62.7M | $-57.6M | $— | — |
| Q4 null | $9.5M | 87.4% | $-71.7M | $-67.4M | $— | — |
| FY null | $262.6M | 98.0% | $-114.9M | $-80.8M | $— | — |
| Q3 null | $41.9M | 100.0% | $-43.8M | $-35.1M | $— | — |
| Q2 null | $22.4M | 100.0% | $-71.5M | $-61.2M | $— | — |
| Q1 null | $188.8M | 100.0% | $71.4M | $82.9M | $— | — |
| Q4 null | $59.2M | 100.0% | $-58.2M | $-45.1M | $— | — |
| FY null | $263.4M | 100.0% | $-250.2M | $-198.9M | $— | — |
| Q3 null | $102.4M | 100.0% | $-60.3M | $-49.2M | $— | — |
| Q2 null | $76.5M | 97.8% | $-48.5M | $-35.2M | $— | — |
| Q1 null | $25.3M | 93.3% | $-83.3M | $-69.4M | $— | — |
| Q4 2023 | $-43.1M | 103.9% | $-165.3M | $-154.8M | $-2.53 | — |